Breast cancers invading the chest wall are a difficult clinical problem, and little evidence exists to guide treatment decisions. Surgical resection can be a useful part of treatment for both curative and palliative purposes in select patients. We are carrying out a prospective trial to evaluate how surgery influences quality of life, and to measure locoregional recurrence, overall survival and morbidity in patients with recurrent breast cancer in the chest wall. Patients with primary tumors that invade the chest wall who fail chemotherapy and radiation therapy are also eligible.
Toronto General Hospital/Princess Maragaret Cancer Center/University Health Network
Clinical Trials.Gov Registration: https://clinicaltrials.gov/ct2/show/NCT03265379